Literature DB >> 10426541

The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain.

C P Stephenson1, G E Hunt, A N Topple, I S McGregor.   

Abstract

Rats were injected with 3,4-methylenedioxymethamphetamine ("Ecstasy") and assessed for changes in locomotor activity and for the expression of the immediate early gene c-fos throughout the brain. A dose-dependent increase in locomotor activity was seen with 3,4-methylenedioxymethamphetamine (0, 5 and 20 mg/kg) that continued for at least 2 h following administration. Dose-dependent increases in c-fos expression were seen in much of the cortex, forebrain, brainstem and cerebellum in rats given 3,4-methylenedioxymethamphetamine. Expression was pronounced in 5-hydroxytryptamine terminal regions including the medial prefrontal cortex, caudate-putamen, nucleus accumbens, olfactory tubercle, islands of Calleja, lateral septum, paraventricular hypothalamus and paraventricular thalamus. High levels of c-fos expression were also seen in the supraoptic and median preoptic nuclei, regions involved in the control of fluid balance and body temperature, respectively. This is potentially important since deaths in 3,4-methylenedioxymethamphetamine users have been linked to hyperthermia and hyponatremia. In the brainstem, two regions of high c-fos expression were Barrington's nucleus, which is involved in micturition, and the pontine reticular nucleus oralis, a region involved in motor control of mastication. Activation of this latter structure may partly explain the bruxism (grinding of the jaw) reported by human 3,4-methylenedioxymethamphetamine users. Robust c-fos expression was seen in the cerebellum, particularly in the flocculus, and this may explain the reported deleterious effects of 3,4-methylenedioxymethamphetamine on balance and co-ordination. Significant c-fos expression was also seen in the ventral tegmental area, amidst the cell bodies of mesolimbic and mesocortical dopamine neurons, and in the median and dorsal raphe, where the serotonergic innervation of the forebrain originates. Double-labelling of fos-positive neurons with 5-hydroxytryptamine showed that only a small number of serotonergic neurons in the raphe expressed c-fos following 3,4-methylenedioxymethamphetamine. The widespread distribution of 3,4-methylenedioxymethamphetamine-induced c-fos expression seen in this study can be linked to the profound alterations in physiological function, mood and behaviour produced by this drug.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426541     DOI: 10.1016/s0306-4522(99)00049-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.

Authors:  Isabel Escobedo; Esther O'Shea; Laura Orio; Veronica Sanchez; Mireia Segura; Rafael de la Torre; Magi Farre; Alfred Richard Green; Maria Isabel Colado
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.

Authors:  J Salzmann; C Canestrelli; F Noble; C Marie-Claire
Journal:  Neuroscience       Date:  2005-11-14       Impact factor: 3.590

3.  Transient inactivation of the paraventricular nucleus of the thalamus enhances cue-induced reinstatement in goal-trackers, but not sign-trackers.

Authors:  Brittany N Kuhn; Marin S Klumpner; Ignacio R Covelo; Paolo Campus; Shelly B Flagel
Journal:  Psychopharmacology (Berl)       Date:  2017-12-28       Impact factor: 4.530

4.  New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.

Authors:  Young-Jung Kim; Shi-Xun Ma; Kwang-Hyun Hur; Youyoung Lee; Yong-Hyun Ko; Bo-Ram Lee; Seon-Kyung Kim; Su-Jeong Sung; Kyeong-Man Kim; Hyoung-Chun Kim; Seok-Yong Lee; Choon-Gon Jang
Journal:  Arch Toxicol       Date:  2021-01-30       Impact factor: 5.153

5.  Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure.

Authors:  Jennifer Kaufling; Elisabeth Waltisperger; Romain Bourdy; Antoine Valera; Pierre Veinante; Marie-José Freund-Mercier; Michel Barrot
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

6.  Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect.

Authors:  Shinji Miyata; Takashi Hamamura; Youmei Lee; Masahito Miki; Toshiaki Habara; Takuro Oka; Shiro Endo; Hideki Taoka; Shigetoshi Kuroda
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

Review 7.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

8.  Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.

Authors:  Julie Salzmann; Cynthia Marie-Claire; Stephanie Le Guen; Bernard P Roques; Florence Noble
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.

Authors:  Thomas J R Beveridge; Annis O Mechan; Marie Sprakes; Qi Pei; Tyra S C Zetterstrom; A Richard Green; J Martin Elliott
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

10.  Sex differences in MDMA-induced toxicity in Sprague-Dawley rats.

Authors:  Sara Soleimani Asl; Mehdi Mehdizadeh; Soudabeh Hamedi Shahraki; Tayebeh Artimani; Mohammad Taghi Joghataei
Journal:  Funct Neurol       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.